Dietary N-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease by Berr, Frieder et al.
Dietary N-3 Polyunsaturated Fatty Acids Decrease Biliary 
Cholesterol Saturation in Gallstone Disease 
FRIEDER BERR, JOSEPH HOLL, DIETER JONGST, SVEN FISCHER, WERNER 0. RICHTER, BERND SEIFFERTH AND 
Department of Medicine II, Klinikum Grosshadern, University of Munich, D-8000 Munich 70, Germany 
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Because fatty acid composition of biliary phospho- 
lipids Muences cholesterol secretion into bile, we 
investigated whether replacement of n-1 monounsat- 
urated or n-6 polyunsaturated fatty acids with n-3 poly- 
unsaturated fatty acids in biliary phosphatidylcholines 
reduces supersaturation with cholesterol and prevents 
precipitation of cholesterol crystals in bile of gallstone 
patients. Seven patients with radiolucent gallstones in 
functioning gallbladders were studied before (control) 
and after 5 wk of dietary supplementation with marine 
fish oil (11.3 &day = 3.75 gm 13-3 polyunsaturated 
fatty acids/day). Duodenal bile was collected for 
analysis during intravenous infusion of cholecysto- 
kinin. Gallbladder emptying in response to cholecysto- 
kinin was comparable before and during intake of n-3 
polyunsaturated fatty acids. Intake of n-3 polyunsatu- 
rated fatty acids increased (p < 0.001) the fractions of 
eicosapentaenoic and docosahexaenoic acids and de- 
creased the fractions of linoleic (p < 0.001) and arachi- 
donic acids (p < 0.02) in biliary phospholipids. Con- 
comitantly, the molar ratio of cholesterol to phospho- 
lipids decreased ( - 19%; p < 0.05). As a consequence, 
the cholesterol saturation index was reduced by - 25% 
(p = O.Ol), from 1.60 f 0.44 to 1.24 f 0.38. However, in 
uitro nucleation time of duodenal bile was not pro- 
longed. The decrease in cholesterol saturation was not 
sufficient to prevent nucleation of cholesterol crystals 
in bile of gallstone patients. In conclusion, our data 
suggest that cholesterol saturation can be influenced 
by the fatty acid composition of the phosphatidylcho- 
lines secreted in bile. (HEPATOLOGY 1992;16:960-967.) 
Formation of gallstones requires at  least two steps - 
secretion of bile supersaturated with cholesterol and 
nucleation of cholesterol crystals (1). Saturation of bile 
with cholesterol can be decreased with intake of bile 
acids in use for gallstone dissolution; bile acids become 
enriched in bile and lower the secretory ratio of 
cholesterol to bile acids (2,3). No attempts have yet been 
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made in cholesterol gallstone disease to lower cholesterol 
saturation of bile by modification of biliary phospho- 
lipids, even though the secretion of cholesterol in bile is 
linked to that of phospholipids (1, 3-6). 
Approximately 95% of biliary phospholipids are phos- 
phatidylcholines, which contain an unsaturated fatty 
acid in position sn-2 and, almost without exception, a 
saturated fatty acid in position sn-1 (7). The constit- 
uents in position sn-2 are quite varied and, for the most 
part, are polyunsaturated fatty acids (PUFAs) (7). They 
can be influenced by the type of PUFA in the diet (8-13) 
because the two families-n-3 PUFAs and n-6 
PUFAs - are essential fatty acids that cannot be inter- 
converted in mammals (14). Dietary n-3 PUFAs were 
incorporated into biliary phosphatidylcholines; they 
lowered cholesterol saturation of bile in hamsters (12) or 
prevented formation of cholesterol monohydrate 
crystals in bile of prairie dogs (15). In healthy human 
subjects, ingestion of n-3 PUFAs (1.5 &day for 6 wk) 
lowered cholesterol saturation of bile (16). Therefore we 
studied in patients with cholesterol gallstones whether 
dietary supplementation with n-3 PUFAs decreases 
cholesterol saturation and prevents formation of cho- 
lesterol crystals in bile. 
SUBJECTS AND METHODS 
Subjects. Seven otherwise healthy patients (five women, 
two men; age range = 27 to 56 yr) with symptomatic gall- 
stones were studied (Table 1). All had radiolucent gallbladder 
stones and visible gallbladders on cholecystography. None had 
hypertriglyceridemia or a serum cholesterol level exceeding 
260 mg/dl or were obese. None had a history of allergy to fish 
protein, excessive alcohol intake or intake (within the last 
6 wk) of antibiotic drugs, laxative drugs or drugs interfering 
with lipid metabolism. The fish oil supplement was well 
tolerated except in one patient, who experienced uncharacter- 
istic upper abdominal discomfort that lasted 5 days. 
Study Protocol. The protocol had been approved apriori by 
the ethics committee of this hospital. All participants gave 
written, informed consent. They were studied twice: first on 
their regular Western diet without supplementation (control 
study) and again after 5 wk of dietary supplementation with 
fish oil (n-3 PUFA study). All ingested 11.3 &day MaxEPA 
oil (in three doses) (Eicosapen; generously provided by Ny- 
comed Arzneimittel GmbH, Munich, Germany); this prepa- 
ration consisted of triglycerides with a fatty acid pattern of 
30% n-3 PUFAs (18% [20: 51 eicosapentaenoic and 12% [22 : 61 
docosahexaenoic acid), 21% oleic acid (18 : 1, n = 9 PUFAs) and 
960 
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TABLE 1. Characteristics of participating gallstone patients 
Body weight Body mam index Serum lipid cholesterol Triglyceridea Apo E 
AL F 37 61 25.18 242 91 E3,E4 
GG F 27 58 21.83 194 67 E3,E4 
WG M 51 13 22.50 258 168 E3,E4 
RM F 40 57 22.27 210 109 E3,E3 
JL M 56 83 25.06 240 96 E3,E3 
AG F 25 53 20.70 200 65 E3,E3 
EH F 36 58 21.56 233 119 E3,E3 
Mean 2 S.D. 3 9 t  11 63 ? 11 22.73 t 1.73 
Subject Sex (yr) (kg) (ks/m4) (mg/dl) (mg/dl) htYPe 
Age 
225 +. 24 102 2 35 - 
28% saturated fatty acids, with small amounts of cholesterol 
(0.2 mg/gm) and vitamin E (2 mg/gm). The daily dose of n-3 
PUFAs was 3.75 gm; that of eicosapentaenoic acid was 
2 gm. A design detailed in a previous report (17) was used for 
control and n-3 PUFA studies. After patients fasted overnight 
(12 hr), duodenal bile was sampled, light-shielded, into an 
ice-cooled beaker through a nasoduodenal tube; gallbladder 
emptying was studied every 5 min on sonographic imaging (18) 
during intravenous infusion of cholecystokinin (CCK) (0.02 
Ivy dog units kg- min for 40 min) (19). Gallstone volume 
W) was calculated from sonographic estimates of the 
maximum diameter (d, = 2a) and the maximal perpendicular 
diameter (d, = 2b), assuming a three-dimensional ellipsoid 
(V = 4 a b2). Bile was collected from 10 to 20 min and from 
20 to 30 min during the CCK infusion, and the darker 
fraction was analyzed. In addition, 0.5-ml specimens of fresh 
duodenal bile were sampled at 10, 15, 20 and 30 min of CCK 
infusion for light microscopy. 
Light Microscopy. The number of cholesterol monohydrate 
crystals per microliter was counted in fresh duodenal bile and 
in an immediately obtained sediment of 200 pl bile (range of 
specific weight = 1.002 to 1.044 gm/ml; 10 min centrifugation 
at 11,000 g). Cholesterol crystals were identified by their 
typical appearance on direct light microscopy and birefrin- 
gence on polarized light microscopy (20, 21); they were 
immediately counted in a hemacytometer. The greatest 
number counted in the sediment at any time point was used for 
statistical analysis. The counting procedure for cholesterol 
crystals was reproducible in different aliquots of the same bile 
specimen (coefficient of variation = 10.1%; n = 10); recov- 
ery = 94% % 15% (mean & S.D.; n = 10) in sediments com- 
pared with the count in native bile (i.e., count of 0.1 pl 
multiplied by factor 10). 
Chenrical Analysis of Bile Samples. The samples were kept 
in chloroforndmethanol (2 : 1, vol/vol) at - 20" C for analysis. 
Cholesterol (22) and lipid phosphorus (23) were measured with 
colorimetric tests; bile acid species were assayed with gas- 
liquid chromatography (GLC) (24). For duodenal bile the 
cholesterol saturation index was calculated (25) according to 
the method of Carey and Small (26) on the basis of actual lipid 
concentrations. For comparison, the saturation index of 
duodenal bile was also calculated (25, 27) for a fixed lipid 
concentration of 10 gm/dl, as assumed for undiluted gall- 
bladder bile. 
The fatty acid species of biliary phospholipids were analyzed 
with GLC (28). Total lipids were extracted from native bile (50 
to 100 p1 with 20 pg diheptadecanoyl phosphatidylcholine as 
internal standard) with chlorofodmethanol and the phos- 
pholipid fraction isolated on Bondelut C,, cartridges (Waters 
Chromatography Division, Millipore Corp., Bedford, MA) (29). 
The phospholipid fraction was refluxed for 1 hr in 3 N 
3 
methanolic HCl at 75" C for acidic transmethylation of 
phospholipid fatty acids. The fatty acid methyl esters were 
extracted with hexane and analyzed with GLC on a cyano- 
propyl siloxane capillary column (CP-Sil 88; Chrompak, 
Middleburg, The Netherlands), which was used with hydrogen 
on a temperature program (80" to 200" C). Fatty acids were 
identified on retention time and cochromatography with 
authentic standards. 
Determination of Nucleation Erne. Time elapsed before in 
uitro appearance of cholesterol crystals from duodenal bile was 
determined by the method of Holan et al. (30) as modified by 
Marks et al. (31). Native duodenal bile ( 2 4 ml) was centrifuged 
for 2 hr at 100,000 g and 25" C to obtain a crystal-free isotropic 
interphase of bile, as described by Holan et al. (30). An aliquot 
of the isotropic interphase was immediately examined micro- 
scopically to confirm the absence of crystals. An aliquot (500 
pl) of the isotropic interphase was added to tubes 1 and 2, 
which contained (a) 5 p1 sodium azide (20%) and (b) a freshly 
prepared mixture (25 pl) of the proteinase inhibitors PMSF 
(final concentration = 1 mmol/L) and soybean trypsin in- 
hibitor (50 pg/ml), the phospholipase inhibitor parabro- 
mophenacyl bromide (0.4 mmol/L) and antibiotics (strepto- 
mycin, 100 pg/ml; penicillin, 100 U/ml, respectively). Samples 
were incubated under nitrogen at 37" C in the dark. Each day 
for 21 days an aliquot (5 to 10 p1) of the incubated bile was 
examined for appearance of cholesterol crystals. Nucleation 
time as observed with incubate b was recorded as the interval 
from the start of the incubation to the first appearance of 
cholesterol crystals in bile. If cholesterol crystals had not 
appeared after 21 days, bile was considered nonnucleating 
(recorded as nucleation time of 21 days). 
The effect of pure L-a-palmitoyl-eicosapentaenoyl phos- 
phatidylcholine (Avanti Polar Lipids Inc., Alabaster, AL) on in 
uitro nucleation time of cholesterol crystals was studied in 
surgical specimens of gallbladder bile obtained from four 
patients (3 women and 1 man; mean age = 46 ? 11 yr) who 
had undergone cholecystectomy for radiolucent gallstones; all 
four native bile specimens had contained cholesterol crystals. 
Crystal-free, isotropic bile was obtained on ultracentrifu- 
gation. L-a-palmitoyl-eicosapentaenoyl phosphatidylcholine 
(10 mg/ml chloroform) was added in appropriate amounts to 
the teat tubes, dried under a stream of nitrogen and redissolved 
in 0.30 ml isotropic bile. Complete dissolution was achieved in 
the samples, as documented by analysis of the concentration 
and the fatty acid pattern of phospholipids. Aliquots of 
isotropic bile (0.30 ml with 0.1% volhol sodium azide) were 
incubated in native form (30) and after addition of 1.0 pmol 
and 1.5 pmol, respectively, of L-a-palmitoyl-eicosapentaenoyl 
phosphatidylcholine under nitrogen at 37" C in the dark and 
examined daily for appearance of cholesterol crystals. 
Serum Lipid Profiles. Serum samples obtained after 12 hr 
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FIG. 1. Effect of dietary n-3 PWAs (3.75 @day for 5 wk) on 
unsaturated fatty acids of biliary phospholipids in seven gallstone 
patients. Eicosapentaenoic acid (20 : 5, n-3) and docosahexaenoic acid 
(22 : 6, n-3) of dietary origin were incorporated into phospholipids of 
bile, where they partly displaced linoleic acid (18: 2, n-6), a-linolenic 
acid (18:3, n-3) and arachidonic acid (20:4, n-6). The fractions of 
palmitoleic acid (16:l) and oleic acid (18:l) did not change. Data 
expressed as mean ? S.D. *p < 0.02; **p < 0.001; 0 = control study; 
0 = n-3 PUFA study. 
n CA CDCA DCA LCA UDCA 
FIG. 2. Pattern of biliary bile acids in seven gallstone patients before 
(0) and after (El) intake of a fish oil supplement (3.75 g n-3 PWAdday) 
for 5 wk. The fraction of cholic acid increased at the expense of 
chenodeoxycholic acid. The pattern of secondary bile acids did not 
change. Data expressed as mean ? S.D. *p = 0.07. CA = cholic acid; 
CDCA = chenodeoxycholic acid; DCA = deoxycholic acid; LCA = 
lithocholic acid; UDCA = ursodeoxycholic acid. 
fasting before and during intake of n-3 PUFAs were analyzed 
enzymatically for cholesterol and triglycerides in total serum 
and in the very low density lipoprotein (VLDL) and high- 
density lipoprotein (HDL) fractions (32). For analysis of 
lipoprotein classes, the VLDL fraction was separated by 
ultracentrifugation (at density d = 1.006 gm/ml at 50,000 rpm 
for 20 hr at 4" C in a Beckman Ti 50 rotor (Beckman 
Instruments, Inc., Fullerton, CA) (33). HDL cholesterol was 
measured in the bottom fraction after precipitation of low- 
density lipoprotein (LDL) with phosphotungstic acid. LDL 
cholesterol concentration was calculated by subtracting HDL 
cholesterol from total cholesterol concentration of the bottom 
- - _  - 
pressed as mean 5 S.D. 
fraction (32, 33). The apolipoprotein E isotype (33) was 
determined before patients' intake of n-3 PUFAs. 
Statistical huzlysie. Statistical significance of differences 
between groups was calculated with Student's t test for paired 
observations after testing of the equality of variances with an 
F test and the Wilcoxon matched-pair, signed-rank test (34). 
All results, unless stated otherwise, are expressed as 
mean * S.D.; p < 0.05 was considered statistically significant. 
RESULTS 
Serum Lipid Concentrations. Intake of fish oil de- 
creased (p < 0.01) triglyceride concentration in serum 
by 26% (from 102 f 25 to 75 f 23 mddl), and triglyc- 
eride concentration in VLDLs by 44% (from 66 f 36 to 
36 & 21 mg/dl) and decreased the VLDL cholesterol 
level by 41% (from 17 f 9 to 10 2 5 mg/dl). The 
concentrations of total cholesterol (+2%) and LDL 
cholesterol ( + 2%) remained unchanged, whereas HDL 
cholesterol level showed a trend (p = 0.08) toward 
increase (from 52 f 15 to 61 f 23 mg/dl). 
Fatty Acid Composition of Biliary Phospholipids. 
Dietary n-3 PUFAs were incorporated into biliary 
phospholipids. The average fraction of eicosapentaenoic 
acid increased from 2.0% f 0.6% to 8.2% '-c 2.2% 
and that of docosahexaenoic acid increased from 
2.4% f 0.4% to 4.2% f 0.6% (p < 0.001 for both) 
during intake of fish oil, whereas a-linolenic acid (18 : 3) 
(1.0% f 0.6% to 0.5% f 0.3%) and the n-6 PUFAs 
linoleic acid (18:2) (29% 2 2% to 23% k 2%) 
(p < 0.001) and (to a lesser extent) arachidonic acid 
(20:4) (7.3% f 0.7% to 6.5% f 0.9%; p < 0.02) were 
partly replaced (Fig. 1). The fractions of palmitic acid 
(16:O) (33% f 3%), stearic acid (18:O) (5.6% f 1.1%) 
and palmitoleic acid (16:1, n-7) (2.5% f 0.8%) did not 
change significantly during intake of fish oil. 
Composition of Biliary Bile Acids. During intake of 
fish oil the fraction of cholic acid in biliary bile acids 
increased from 26.3% f 4.0% to 32.3% k 4.3% (p = 
0.07)) and the ratio of cholic acid to chenodeoxycholic 
acid increased from 0.72 f 0.16 to 1.02 f 0.28 (p = 
0.01). The fraction of chenodeoxycholic acid decreased 
on average by 5.5% (NS). The fractions of secondary 
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TABLE 2. Effect of fish oil intake on cholesterol content and nucleation of cholesterol monohydrate crystals in 
CCK-stimulated bile 
Total lipids Nucleation time Cholesterol crystals 
Subject Control Fish oil Control Fish oil Control Fishoil Control Fieboil 
Cgm/du Cholesterol saturation index" days (count/pl) 
AJ.4 2.90 2.09 2.26 1.97 
GG 1.17 5.03 1.31 0.92 
WG 1.52 4.10 1.78 1.41 
RM 1.36 5.17 1.66 0.99 
JL 3.08 2.80 1.44 0.92 
AG 3.83 2.44 1.02 1.13 
EH 2.57 2.77 2.13 1.34 
Mean S.D. 2.35 ? 1.01 3.49 2 1.27 1.60 t 0.44 1.24 ? 0.38 
6.0 13.8 
10.0 4.8 
0.8 1.4 
17.9 19. 
19.0 21.0 
21.0 18.0 
0.9 0.9 
10.8 t 8.6 11.4 2 8.8 
9 54 
0 202 
0 30 
1 253 
10 0 
5 9 
42 45 
10 k 15 85 t 100 
"Calculated from actual lipid concentrations according to the method of Carey and Small (26). Cholesterol saturation decreased by 20% (fmm 
1.27 ? 0.34 to 1.01 t 0.27 [p = 0.021) when calculated from relative lipid content (27) assuming a fixed total lipid concentration of 10 gm/dl 
for undiluted bile. 
bile acids deoxycholic acid, lithocholic acid and ursode- 
oxycholic acid did not change significantly (Fig. 2). 
Composition of Biliary Lipids. The cholesterol satu- 
ration index (26) decreased by 25%, from 1.66 L 0.44 to 
1.24 ? 0.38 (p = 0.01) (Table 2; Fig. 31, and the molar 
ratio of cholesterol to phospholipids decreased by 19% 
(p c 0.05) during intake of fish oil; the ratio of phos- 
pholipids to bile acids did not change. Bile acid concen- 
tration (26 L 12 vs. 40 L 18 mmoVL) and total lipid 
content (2.4 k 0.9 vs. 3.5 k 1.3 gm/ml) (Table 2) of 
CCK-stimulated duodenal bile were increased on av- 
erage by 50% and 43% (NS), respectively. 
Cholesterol Monohydrate Crystals in Bile. CCK- 
stimulated duodenal bile showed cholesterol monohy- 
drate crystals in five of seven patients during the control 
study and in six of seven patients during fish oil intake. 
Three subjects (GG, WG, RM) had at least 10 times more 
cholesterol crystals and a marked increase (2.7-fold to 
4.3-fold) of total lipid concentration in bile; two (WG, 
RM) had also emptied a higher fraction of gallbladder 
volume during fish oil intake. The increase of the 
average count of cholesterol crystals in bile during 
ingestion of fish oil was not statistically significant 
(p 2 0.10). The count of cholesterol crystals was corre- 
lated neither with the nucleation time of duodenal bile 
(r = 0.07) nor with the cholesterol saturation index 
(r = -0.35). 
Choksterol Crystal Nucleation Time. In uitro, the 
nucleation time of duodenal bile was not changed by 
intake of fish oil (Table 2; Fig. 3). Nucleation time of 
duodenal bile was correlated in an inverse linear fashion 
with the cholesterol saturation index (r = -0.45; 
p = O.OS), but not with the count of cholesterol mono- 
hydrate crystals (r = 0.07; NS). 
When pure palmitoyl-eicosapentaenoyl-phosphatidyl- 
choline was added in uitro to surgical specimens of 
isotropic, supersaturated gallbladder bile from four 
patients with cholesterol gallstones in amounts that 
increased the eicosapentaenoic acid fraction of the 
phospholipids, but barely decreased cholesterol satu- 
ration, the nucleation time for cholesterol crystals was 
prolonged (Table 3). 
Gallbladder Emptying by CCK. The volume of the 
gallbladder in the fasting state was not different before 
and during intake of fish oil. Impaired emptying of the 
gallbladder in response to the CCK infusion (i.e., 
emptying of less than 50% of the fasting volume [191), 
was not improved in two gallstone patients (AL, GG); 
nor was normal emptying (in JL, AG, EH) impaired by 
ingestion of fish oil. Only two patients (WG, RM) with 
emptying in the lower range of normal had higher 
fractional emptying of the gallbladder during intake of 
fish oil (Table 4). In the entire group, the time course of 
gallbladder emptying (Fig. 4) and the fraction of the 
gallbladder volume emptied (Table 4) were very similar 
before and during intake of fish oil. 
DISCUSSION 
Supplementation of a Western diet with marine fish 
oil rich in n-3 PUFAs (3.75 gm/day) markedly increased 
the fraction of the n-3 PUFAs eicosapentaenoic acid 
(20:5; n-3) and docosahexaenoic acid (22:6; 11-31 and 
replaced about one third of the linoleic acid (18 : 2; 11-61 
in the phospholipids of bile. The cholesteroYphospho- 
lipid molar ratio and cholesterol saturation decreased by 
19% and 25%, respectively, whereas the nucleation time 
of duodenal bile did not change. But this neither 
prevented precipitation of cholesterol monohydrate 
crystals in bile nor improved emptying of the gallbladder 
in gallstone patients. 
This raises the question of whether patients were 
given adequate doses of n-3 PUFAs. Doses in the range 
of 2 gm to 20 g m  of n-3 PUFAs/day (as marine fish oil) 
have been used to reduce triglyceride and VLDL con- 
centrations in serum (35-40) by decreasing hepatic 
secretion of VLDL (38). In moderate hypertriglyceri- 
demia, the maximum effect on triglyceride levels had 
already been achieved with a daily dose of 3 to 5 gm n-3 
PUFAs and was characterized by an approximate 50% 
lowering of VLDL triglycerides and VLDL cholesterol, 
little change in LDL cholesterol level and a small 
decrease (35-38) or small increase (39, 40) of HDL 
cholesterol. In our participants, who all had normotri- 
glyceridemia, these effects on serum lipid levels were 
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TABLE 3. Effect in uitro of 16:0,20:S-phosphatidylcholine on nucleation time of gallbladder bile samples 
Amount of added 
16:O. 20: 5-phosphatidylcholine Total lipids Cholesterol Nucleation time 
(pmoUO.30 ml bile) (gm/dl) saturation index Eicosapentaenoic Linoleic (days) 
Phospholipid fatty acids (%) 
0 
1.0 
1.5 
9.8 & 5.90 1.16 2 0.23 1.7 2 0.9 28.2 & 2.3 2.7 f 2.4 
10.2 t 6.1 1.12 +- 0.20 5.9 f 4.0 25.8 ? 2.1 11.3 & 6.0 
16.1 f 8.3 10.3 t 6.0 1.10 +- 0.17 7.6 f 5.2 24.8 f 2.5 
Data expressed as mean & S.D. (n = 4). 
TABLE 4. Gallbladder emptying by intravenous CCK" 
Fasting volume Fraction emptied Rate constant 
(ml) (% of fasting vo1ume)l of emptying' 
Stone volume 
Subject (ml) Control Fish oil Control Fish oil Control Fish oil 
AL 0.5 20 21 30.0 22.0 
GG 1.0 11.5 16 30.4 26.7 
WG 1.9 26.5 27.5 50.8 97.0 
RM 1.8 15 22 65.8 86.6 
JL 9.7 27 36 93.4 91.3 
AG 1.0 12 12.5 75.0 69.0 
EH 3.5 31.5 31 85.7 89.1 
Mean & S.D. 2.8 2 3.2 23.4 f 10.2 23.7 +- 8.3 61.6 ? 25.4 68.8 & 31.6 
0.013 
0.031 
0.034 
0.020 
0.054 
0.040 
0.053 
0.035 2 0.015 
0.008 
0.009 
0.123 
0.055 
0.046 
0.066 
0.051 2 0.043 
d - 
"Determined by serial sonographic imaging and calculation of volume of the gallbladder during intravenous infusion of CCK (0.02 Ivy dog 
*The estimated stone volume had been subtracted from the fasting volume and from the residual volume (after 40-min CCK infusion); the 
'Slope of the first-order linear function of gallbladder volumes vs. time (18). 
dBile was sampled during upper gastrointestinal endoscopy; only fasting and residual volumes of the gallbladder were determined. 
units-kg-l-min-'for 40 min). 
fraction emptied (%I was then calculated as 100 x W,- casting - Vmrr- residual)mmmted fasting. 
reproduced by a dose of 3.75 &day of n-3 PUFAs, 
confirming adequate dosage and good compliance. 
The dose of fish oil (11.3 gm/day = 3.75 &day n-3 
PUFAs) administered in our study displaced about one 
third of the linoleic acid, the major unsaturated fatty 
acid of biliary phospholipids, but only very small 
amounts of arachidonic acid and none of the oleic acid 
(Fig. 1). Unsaturated phospholipid fatty acids in bile 
predominantly represent distinct phosphatidylcholine 
species because at  least 95% of biliary phospholipids are 
phosphatidylcholines and the unsaturated fatty acids of 
biliary phosphatidylcholines are located in position sn-2 
(except for some 3% to 5% of oleic acid that resides in 
position sn-1 of 18: 1-18: 2 phosphatidylcholine) (7). The 
most abundant fatty acid in position sn-2 is linoleic acid 
(18 : 2,n-6), primarily in 16 : 0,18 : 2-phosphatidylcholine 
(7). Dietary n-3 PUFAs displaced mainly 18:2- 
containing phosphatidylcholines with 20 : 5-containing 
and 22 : 6-containing phosphatidylcholines. Several 
factors may contribute to this rather selective exchange. 
(a) Highly unsaturated fatty acids are preferred over 
monounsaturated or diunsaturated fatty acids for the 
sn-2 position of phosphatidylcholines destined for se- 
cretion into bile (41,42). This could explain why dietary 
n-3 PUFAs displaced linoleic acid rather than arachi- 
donic acid in biliary phospholipids. (b) Similar changes of 
the fatty acid pattern with poor displacement of arachi- 
donic acid by n-3 PUFAs have been observed in serum 
phospholipids in response to fish oil intake (43). (c) The 
magnitude and selectivity of displacement of fatty acid 
species could also depend on the magnitude of the 
respective fatty acid fraction in biliary phosphatidylcho- 
lines before fish oil intake and on the entire fatty acid 
spectrum of the ingested fish oil. Because the gallstone 
patients in this study had normal fractions of arachi- 
donic acid, not increased fractions (441, the fraction of 
displaceable arachidonyl lecithins may have been low 
before intake of fish oil. Furthermore, the fish oil 
contained only 29% of fatty acids as n-3 PUFAs, but 
some 21% as oleic acid (18: 1, n-9). Failure to substitute 
any of the oleic acid located mainly in 16: 0, 18: 1- 
phosphatidylcholines (7) by n-3 PUFAs may be related 
to the considerable dose of oleic acid contained in the fish 
oil preparation. 
A 25% decrease in cholesterol saturation of bile was 
observed during intake of fish oil (Fig. 3). This was 
caused entirely by a decrease in the cholesterol/phospho- 
lipid molar ratio; the phospholipidbile acid molar ratio 
remained constant. This decrease in cholesterol/phos- 
pholipid molar ratio cannot be attributed to the small 
change of the bile acid pattern. How, then, can the de- 
crease by n-3 PUFAs of the cholesteroVphospholipid 
ratio in bile be explained? 
Dietary n-3 PUFAs could have reduced the amount of 
free cholesterol available in the liver for biliary se- 
cretion. One study has revealed that excess cholesterol 
secreted in bile of subjects with cholesterol gallstones 
can result from inappropriately high synthesis of cho- 
lesterol in the liver (1). As a consequence, inhibition of 
cholesterol synthesis should decrease biliary secretion of 
cholesterol. Dietary n-3 PUFAs suppress the rate of 
hepatic synthesis of cholesterol in the rat (45), but it has 
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not yet been studied whether they have the same effect 
in human beings. 
Alternatively, the cholesterol/phospholipid ratio in 
bile could have been lowered by the changes in biliary 
phosphatidylcholine species during intake of fish oil. In 
a previous study in healthy women and cholesterol 
gallstone patients we observed positive linear correla- 
tions between the cholesterol saturation index (and the 
cholesteroVphospholipid ratio) and the fractions of oleic 
acid (18: 1) and arachidonic acid (20: 4) and an inverse 
relationship between the saturation index and the 
fraction of linoleic acid (18:2), palmitoleic acid (16 : 1) 
and eicosapentaenoic acid (20 : 5 )  in biliary phospholipids 
(44). These correlations could represent differences 
among the respective biliary phosphatidylcholine species 
in cholesteroVphospholipid packing into the membrane 
of biliary vesicles. In this case, eicosapentaenoic acid- 
containing phosphatidylcholine would pack less choles- 
terol into secretory vesicles than, for instance, phos- 
phatidylcholines containing arachidonic acid, oleic acid 
or even linoleic acid. The moderate decrease in choles- 
terol saturation during intake of fish oil could be 
explained by the fact that n-3 PUFAs displaced phos- 
phatidylcholine containing linoleic acid, which also is 
associated with low cholesterol saturation (7,44), rather 
than phosphatidylcholines containing arachidonic acid 
or oleic acid. Also in the hamster, the secretory ratio of 
cholesterol to phospholipids in bile was decreased when 
linoleic acid in biliary phosphatidylcholines was dis- 
placed in part with n-3 PUFAs of dietary origin (12). A 
study in African green monkeys that was published after 
conclusion of this study showed similar effects. Feeding 
of a fish-oil-supplemented diet for 2V2 to 3 yr (compared 
with a lard-supplemented diet) led to a similar modifi- 
cation of phospholipid fatty acids and to 25% lower 
cholesterol saturation of bile without significant differ- 
ences in biliary bile acids. The fish oil diet was also 
associated with a lower rate of gallstone formation (22% 
vs. 67%) (13). 
L-a-16: 0,20 : 5-phosphatidylcholine, which is the 
phosphatidylcholine species mainly increased in bile by 
dietary n-3 PUFAs, retards nucleation of cholesterol 
crystals (Table 3) when added in vztro to supersaturated 
gallbladder bile in proportions similar to those found in 
duodenal bile during fish oil intake (compare Fig. 1). 
However, the change in phosphatidylcholine fatty acids 
induced by dietary n-3 PUFAs did not prolong nucle- 
ation time of duodenal bile in our patients (Fig. 3). 
Certainly nucleation time is longer in duodenal bile than 
in gallbladder bile (31); therefore further prolongation 
could be difficult to detect in duodenal bile. In addition, 
other factors could have contributed to this apparent 
lack of effect on native duodenal bile. The 49% average 
increase in lipid concentration during intake of fish oil 
could have offset prolongation of nucleation time; 
according to Marks et al. (311, nucleation time is shorter 
by 31% in bile with a high lipid concentration (11.3 
gm/dl) than in diluted bile (lipids, 7.6 gm/dl). Fur- 
thermore, during intake of fish oil 16:0,20:5- 
phosphatidylcholine might have displaced another phos- 
Cholecystokinin E 
Time (mid 
FIG. 4. Gallbladder emptying during intravenous infusion of 
cholecystokinin (0.02 Ivy dog units. kg-'. min-' (18, 19) in six 
gallstone patients before (0 = control) and after intake for 5 wk of 
marine fish oil at a daily dose of 3.75 gm n-3 PUFAs (0 = on n-3 
PUFA). No significant differences in gallbladder emptying were seen. 
Data expressed as mean i S.D. 
phatidylcholine species with similar retardant effect on 
cholesterol nucleation, whereas during the in uitro 
experiment the concentrations of all other phosphati- 
dylcholine species remained nearly constant. Pre- 
sumably 16 : 0,20 : 5-phosphatidylcholine mainly dis- 
placed 16: 0,18: 2-phosphatidylcholine (see Fig. 11, an- 
other hydrophilic phosphatidylcholine species, which 
facilitates micellar dissolution of multilamellar choles- 
teroVphosphatidylcholine vesicles by bile salts (46) and 
so could prolong the time for nucleation of cholesterol 
crystals. 
The count of cholesterol crystals in duodenal bile 
(Table 2) appears to bear qualitative (presence vs. 
absence) rather than quantitative significance because 
the number of crystals counted was correlated neither 
with the nucleation time nor with the cholesterol 
saturation index of bile. This raises the possibility that 
the crystal count in duodenal bile depends on the 
expulsion of cholesterol crystals from the gallbladder. 
The expulsion of crystals may have been facilitated 
during fish oil intake (e.g., by decreased adherence to the 
mucin layer of the gallbladder) or, in two patients (WG, 
RM), by enhanced gallbladder emptying. 
The change in phosphatidylcholine fatty acids induced 
by dietary n-3 PUFAs did not prevent formation of 
cholesterol crystals in supersaturated bile of gallstone 
patients (Table 2). This observation is in agreement with 
the lack of effect on the nucleation time of duodenal bile. 
By contrast, in the prairie dog model of gallstone 
formation dietary fish oil prevented precipitation of 
cholesterol crystals in supersaturated gallbladder bile 
(15). Which factors could have contributed to the 
different responses in human subjects and prairie dogs? 
First, in the prairie dog model dietary n-3 PUFAS may 
have interfered with prostaglandin formation (15). 
Dietary n-3 PUFAs can decrease formation of prosta- 
glandins F,, and E, by substituting as substrate 
eicosapentaenoic (20 : 5, n-3) for arachidonic acid (20 : 4, 
11-61 (47). Inhibition of prostaglandin synthesis in 
gallbladder tissue by aspirin prevented hypersecretion of 
mucous glycoproteins and formation of cholesterol 
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crystals in the gallbladder of the cholesterol-fed prairie 
dog in an earlier study (48), but not in recent studies (49, 
50). In any case, our human study probably interfered 
little with prostaglandin formation in the gallbladder 
because very little arachidonic acid had been displaced 
by eicosapentaenoic acid and docosahexaenoic acid in 
biliary phospholipids. Second, in the prairie dog dietary 
n-3 PUFAs prevented crystal formation in the absence of 
gallstones (15), whereas in our human study gallstones 
had already been present. The high coincidence (80% to 
100%) of cholesterol gallstones and presence of choles- 
terol crystals in gallbladder bile (21, 51, 52) raises the 
possibility that these crystals nucleated on the free 
cholesterol surfaces of the stones and were shed into 
bile. During fish oil intake cholesterol crystals may have 
been detached more easily by the surfactant effects of 
the more hydrophilic phosphatidylcholines. Third, in- 
creasing the bile acid concentration of supersaturated 
bile in the gallbladder enhances formation of very 
cholesterol rich phospholipid vesicles, which precede 
formation of cholesterol crystals (53). This phenomenon 
could contribute to formation of cholesterol crystals in 
saturated bile during intake of fish oil. Thus only those 
patients who had high increases in lipid and bile acid 
concentration during fish oil intake showed striking 
increases in crystal count. 
In summary, supplementation of a Western diet with 
fish oil rich in n-3 PUFAs (3.75 &day) raised the 
content of the n-3 PUFAs eicosapentaenoic acid and 
docosahexaenoic acid in biliary phosphatidylcholines 
and partly displaced linoleic acid-containing phosphati- 
dylcholine species in bile. The arachidonic acid fraction 
of biliary phosphatidylcholines, which had been in the 
normal range in these gallstone patients, decreased very 
little during intake of fish oil. These changes in fatty 
acids of biliary phospholipids were associated with a 
lower cholesteroVphospholipid molar ratio and choles- 
terol saturation of bile, most likely caused by lecithin 
species-dependent coupling of cholesterol for secretion. 
However, intake of n-3 PUFAs did not protect gallstone 
patients from nucleation of cholesterol crystals in 
supersaturated gallbladder bile; nor did it improve 
emptying of the gallbladder. Therefore the effects of fish 
oil in our study are not sufficient to recommend its use 
for medical treatment or prophylaxis of gallstones. 
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